Montenegro

Montenegro

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.62 (0.53 - 0.70) 2019 Modelled IHME
0.62 (0.53 - 0.70) 2018 Modelled IHME
0.62 (0.53 - 0.72) 2017 Modelled IHME
0.64 (0.53 - 0.74) 2016 Modelled IHME
0.65 (0.54 - 0.76) 2015 Modelled IHME
0.66 (0.55 - 0.77) 2014 Modelled IHME
0.67 (0.56 - 0.78) 2013 Modelled IHME
0.68 (0.58 - 0.78) 2012 Modelled IHME
0.69 (0.59 - 0.80) 2011 Modelled IHME
0.7 (0.60 - 0.81) 2010 Modelled IHME
0.71 (0.61 - 0.82) 2009 Modelled IHME
0.72 (0.62 - 0.83) 2008 Modelled IHME
0.73 (0.63 - 0.85) 2007 Modelled IHME
0.74 (0.63 - 0.86) 2006 Modelled IHME
0.75 (0.63 - 0.88) 2005 Modelled IHME
0.76 (0.64 - 0.89) 2004 Modelled IHME
0.77 (0.65 - 0.90) 2003 Modelled IHME
0.78 (0.66 - 0.90) 2002 Modelled IHME
0.78 (0.67 - 0.91) 2001 Modelled IHME
0.79 (0.67 - 0.91) 2000 Modelled IHME
0.79 (0.67 - 0.91) 1999 Modelled IHME
0.79 (0.67 - 0.91) 1998 Modelled IHME
0.79 (0.67 - 0.91) 1997 Modelled IHME
0.79 (0.66 - 0.91) 1996 Modelled IHME
0.79 (0.66 - 0.92) 1995 Modelled IHME
0.78 (0.66 - 0.91) 1994 Modelled IHME
0.78 (0.66 - 0.90) 1993 Modelled IHME
0.77 (0.65 - 0.89) 1992 Modelled IHME
0.76 (0.64 - 0.88) 1991 Modelled IHME
0.75 (0.63 - 0.87) 1990 Modelled IHME
1.87 (0.31 - 11.53) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.09 (0.06 - 0.12) 2019 Modelled IHME
0.09 (0.07 - 0.12) 2018 Modelled IHME
0.1 (0.07 - 0.13) 2017 Modelled IHME
0.1 (0.07 - 0.13) 2016 Modelled IHME
0.09 (0.06 - 0.13) 2015 Modelled IHME
0.09 (0.06 - 0.12) 2014 Modelled IHME
0.09 (0.06 - 0.11) 2013 Modelled IHME
0.08 (0.06 - 0.10) 2012 Modelled IHME
0.07 (0.05 - 0.10) 2011 Modelled IHME
0.07 (0.05 - 0.10) 2010 Modelled IHME
0.11 (0.08 - 0.14) 2009 Modelled IHME
0.2 (0.14 - 0.26) 2008 Modelled IHME
0.31 (0.22 - 0.41) 2007 Modelled IHME
0.4 (0.29 - 0.53) 2006 Modelled IHME
0.44 (0.32 - 0.60) 2005 Modelled IHME
0.45 (0.32 - 0.61) 2004 Modelled IHME
0.46 (0.33 - 0.62) 2003 Modelled IHME
0.46 (0.33 - 0.62) 2002 Modelled IHME
0.47 (0.33 - 0.62) 2001 Modelled IHME
0.47 (0.33 - 0.63) 2000 Modelled IHME
0.47 (0.33 - 0.62) 1999 Modelled IHME
0.47 (0.33 - 0.62) 1998 Modelled IHME
0.46 (0.33 - 0.62) 1997 Modelled IHME
0.46 (0.32 - 0.62) 1996 Modelled IHME
0.46 (0.31 - 0.62) 1995 Modelled IHME
0.45 (0.32 - 0.61) 1994 Modelled IHME
0.45 (0.31 - 0.60) 1993 Modelled IHME
0.44 (0.31 - 0.59) 1992 Modelled IHME
0.43 (0.31 - 0.57) 1991 Modelled IHME
0.42 (0.30 - 0.56) 1990 Modelled IHME
0.65 (0.10 - 4.40) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
20 (14 - 28) 2019 Modelled IHME
20 (14 - 28) 2018 Modelled IHME
20 (14 - 29) 2017 Modelled IHME
22 (15 - 30) 2016 Modelled IHME
23 (16 - 32) 2015 Modelled IHME
23 (16 - 32) 2014 Modelled IHME
23 (16 - 32) 2013 Modelled IHME
23 (16 - 32) 2012 Modelled IHME
23 (17 - 32) 2011 Modelled IHME
23 (17 - 32) 2010 Modelled IHME
23 (17 - 32) 2009 Modelled IHME
24 (17 - 32) 2008 Modelled IHME
24 (17 - 32) 2007 Modelled IHME
24 (17 - 33) 2006 Modelled IHME
24 (17 - 33) 2005 Modelled IHME
24 (17 - 33) 2004 Modelled IHME
24 (17 - 33) 2003 Modelled IHME
24 (17 - 33) 2002 Modelled IHME
24 (17 - 33) 2001 Modelled IHME
24 (17 - 33) 2000 Modelled IHME
24 (18 - 33) 1999 Modelled IHME
24 (17 - 33) 1998 Modelled IHME
24 (17 - 33) 1997 Modelled IHME
24 (17 - 33) 1996 Modelled IHME
24 (17 - 33) 1995 Modelled IHME
24 (17 - 33) 1994 Modelled IHME
24 (17 - 32) 1993 Modelled IHME
24 (17 - 32) 1992 Modelled IHME
24 (17 - 32) 1991 Modelled IHME
23 (17 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
73 2018 Survey/reported WHO/UNICEF
73 2017 Survey/reported WHO/UNICEF
75 2016 Survey/reported WHO/UNICEF
82 2015 Survey/reported WHO/UNICEF
87 2014 Survey/reported WHO/UNICEF
90 2013 Survey/reported WHO/UNICEF
90 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
90 2010 Survey/reported WHO/UNICEF
87 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
90 2007 Survey/reported WHO/UNICEF
90 2006 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.93 (0.75 - 1.14) 2019 Modelled IHME
0.92 (0.75 - 1.13) 2018 Modelled IHME
0.92 (0.74 - 1.13) 2017 Modelled IHME
0.91 (0.74 - 1.12) 2016 Modelled IHME
0.9 (0.73 - 1.11) 2015 Modelled IHME
0.9 (0.73 - 1.10) 2014 Modelled IHME
0.89 (0.72 - 1.09) 2013 Modelled IHME
0.88 (0.72 - 1.08) 2012 Modelled IHME
0.88 (0.71 - 1.08) 2011 Modelled IHME
0.88 (0.71 - 1.08) 2010 Modelled IHME
0.87 (0.71 - 1.08) 2009 Modelled IHME
0.87 (0.71 - 1.08) 2008 Modelled IHME
0.87 (0.71 - 1.08) 2007 Modelled IHME
0.87 (0.71 - 1.08) 2006 Modelled IHME
0.87 (0.71 - 1.09) 2005 Modelled IHME
0.87 (0.70 - 1.08) 2004 Modelled IHME
0.87 (0.70 - 1.08) 2003 Modelled IHME
0.86 (0.69 - 1.07) 2002 Modelled IHME
0.86 (0.69 - 1.07) 2001 Modelled IHME
0.85 (0.68 - 1.06) 2000 Modelled IHME
0.85 (0.68 - 1.05) 1999 Modelled IHME
0.84 (0.68 - 1.04) 1998 Modelled IHME
0.83 (0.67 - 1.03) 1997 Modelled IHME
0.83 (0.67 - 1.02) 1996 Modelled IHME
0.82 (0.66 - 1.01) 1995 Modelled IHME
0.82 (0.66 - 1) 1994 Modelled IHME
0.81 (0.65 - 1) 1993 Modelled IHME
0.8 (0.65 - 1) 1992 Modelled IHME
0.8 (0.64 - 0.99) 1991 Modelled IHME
0.79 (0.63 - 0.99) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
41.6 (23.70 - 62.10) 2019 Modelled Granados-Garcia V et al, 2019
43.4 (39.80 - 47.10) 2008 Modelled Degenhardt L et al, 2017
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
26 (18 - 34) 2019 Modelled IHME
26 (18 - 34) 2018 Modelled IHME
26 (18 - 34) 2017 Modelled IHME
25 (17 - 34) 2016 Modelled IHME
25 (17 - 34) 2015 Modelled IHME
25 (17 - 34) 2014 Modelled IHME
25 (17 - 34) 2013 Modelled IHME
25 (17 - 34) 2012 Modelled IHME
25 (17 - 33) 2011 Modelled IHME
25 (18 - 33) 2010 Modelled IHME
25 (18 - 33) 2009 Modelled IHME
25 (18 - 33) 2008 Modelled IHME
25 (17 - 33) 2007 Modelled IHME
25 (17 - 33) 2006 Modelled IHME
25 (17 - 33) 2005 Modelled IHME
25 (17 - 33) 2004 Modelled IHME
25 (17 - 33) 2003 Modelled IHME
25 (17 - 33) 2002 Modelled IHME
25 (17 - 33) 2001 Modelled IHME
25 (17 - 33) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
24 (17 - 32) 1998 Modelled IHME
24 (17 - 32) 1997 Modelled IHME
24 (17 - 32) 1996 Modelled IHME
24 (17 - 32) 1995 Modelled IHME
24 (17 - 32) 1994 Modelled IHME
24 (17 - 32) 1993 Modelled IHME
24 (17 - 32) 1992 Modelled IHME
24 (17 - 31) 1991 Modelled IHME
24 (17 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.62 (%)
2019
(0.53 - 0.7(%))
IHME
HCV (RNA/cAg+)
0.93 (%)
2019
(0.75 - 1.14(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
22
2019
(16 - 29)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
25
2019
(18 - 33)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.09 (%)
2019, latest modelled
(0.06 - 0.12(%))
IHME

Prevalence PWID

HCV
41.60 (%)
2019, latest modelled
(23.70 - 62.10(%))
Granados-Garcia V et al, 2019

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines